CRDFNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Cardiff Oncology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.89−0.02 (-1.71%)
Close on Oct 19, 2026
- Market cap
- $60.58M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Cardiff Oncology's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 22, 2026 | Oct 22, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 26, 2026 | Aug 26, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2026 | Jul 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | May 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 19, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2026 | Apr 23, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 6, 2026 | Apr 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2026 | Apr 2, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2026 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 24, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2026 | Jan 27, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2025 | Jul 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 29, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2025 | Jun 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 17, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 3, 2025 | Jan 6, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 10, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 10, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2024 | Jun 20, 2024 | SEC EDGAR |
| Current report | 8-K | May 30, 2024 | Jun 3, 2024 | SEC EDGAR |
| Current report | 8-K | May 2, 2024 | May 2, 2024 | SEC EDGAR |